JPRN-UMIN000041754Completed未知
Predictors of abatacept efficacy in immunomics - PREDICTABA study
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- The University of Tokyo
- Enrollment
- 105
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients treated with more than 3 types of biologics previously Patients with a history of hypersensitivity to any of the ingredients of the abatacept product Patients with a concurrent condition secondary to malignancy Patients with active infection Patients who are pregnant or breastfeeding, or those wishing pregnancy, childbearing, or breastfeeding Patients ineligible for study participation in the opinion of the investigator or subinvestigator
Investigators
Similar Trials
Recruiting
Phase 4
Can abatacept induce immunological remission under tight control in rheumatoid arthritis patient?Rheumatoid arthritisJPRN-UMIN000005570Department of Rheumatosurgery, Osaka City University Medical School50
Recruiting
Phase 3
Abatacept in Immune Checkpoint Inhibitor MyocarditisMyocarditis AcuteCancerNCT05335928Massachusetts General Hospital390
Recruiting
Not Applicable
Abatacept Research Outcome as a First-line Biological Agent in the Real WorldRheumatoid ArthritisJPRN-UMIN000004651Division of Rheumatology Department of Internal Medicine, Hyogo College of Medicine100
Not yet recruiting
Unknown
Biomarker Screening for Immunotherapy Response Evaluation using Microneedle Patch in Patients with Allergic RhinitisDiseases of the respiratory systemKCT0008534Yonsei University Health System, Severance Hospital30
Active, not recruiting
Not Applicable
Evaluation of Belatacept as First-line Immunosuppression in De Novo Liver Transplant Recipients Revised Protocol Number 04, incorporating Amendments 02, 03, 04 and 05 (version 10.0 dated 20-Nov-09)+ Pharmacogenetics Blood Sample Amendment Number 01 - Site Specific, version 2.0 dated 20-Jul-07First time recipient of a deceased donor liver transplantMedDRA version: 9.1Level: LLTClassification code 10062016Term: ImmunosuppressionMedDRA version: 9.1Level: LLTClassification code 10024714Term: Liver transplantEUCTR2007-002125-68-DEBristol-Myers Squibb International Corporation275